VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer
出版年份 2019 全文链接
标题
VGLL4 interacts with STAT3 to function as a tumor suppressor in triple-negative breast cancer
作者
关键词
-
出版物
EXPERIMENTAL AND MOLECULAR MEDICINE
Volume 51, Issue 11, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-11-20
DOI
10.1038/s12276-019-0338-8
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Triple negative breast cancer: Emerging therapeutic modalities and novel combination therapies
- (2018) Alice Lee et al. CANCER TREATMENT REVIEWS
- Pembrolizumab monotherapy for previously untreated, PD-L1-positive, metastatic triple-negative breast cancer: cohort B of the phase II KEYNOTE-086 study
- (2018) S Adams et al. ANNALS OF ONCOLOGY
- Role of everolimus in the treatment of metastatic HER2-negative/HR-positive breast cancer
- (2017) Paolo Pronzato Future Oncology
- BioSITe: A Method for Direct Detection and Quantitation of Site-Specific Biotinylation
- (2017) Dae In Kim et al. JOURNAL OF PROTEOME RESEARCH
- STAT3 but Not HIF-1α Is Important in Mediating Hypoxia-Induced Chemoresistance in MDA-MB-231, a Triple Negative Breast Cancer Cell Line
- (2017) Hoda Soleymani Abyaneh et al. Cancers
- Phosphorylation of STAT3 at Tyr705 regulates MMP-9 production in epithelial ovarian cancer
- (2017) Zan-Hui Jia et al. PLoS One
- JAK-STAT signaling in cancer: From cytokines to non-coding genome
- (2016) Jan Pencik et al. CYTOKINE
- A novel synthetic Asiatic acid derivative induces apoptosis and inhibits proliferation and mobility of gastric cancer cells by suppressing STAT3 signaling pathway
- (2016) Gang Wang et al. OncoTargets and Therapy
- MiR-454 Prompts Cell Proliferation of Human Colorectal Cancer Cells by Repressing CYLD Expression
- (2015) Hong-Liang Liang et al. Asian Pacific Journal of Cancer Prevention
- Constitutive activation of STAT3 in breast cancer cells: A review
- (2015) Kasturi Banerjee et al. INTERNATIONAL JOURNAL OF CANCER
- VGLL4 inhibits EMT in part through suppressing Wnt/β-catenin signaling pathway in gastric cancer
- (2015) Hui Li et al. MEDICAL ONCOLOGY
- Palbociclib in Hormone-Receptor–Positive Advanced Breast Cancer
- (2015) Nicholas C. Turner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of FOXO1 by small interfering RNA enhances proliferation and inhibits apoptosis of papillary thyroid carcinoma cells via Akt/FOXO1/Bim pathway
- (2015) Hong-ming Song et al. OncoTargets and Therapy
- MicroRNA-195 inhibits proliferation, invasion and metastasis in breast cancer cells by targeting FASN, HMGCR, ACACA and CYP27B1
- (2015) Richa Singh et al. Scientific Reports
- Multiple regulation pathways and pivotal biological functions of STAT3 in cancer
- (2015) Jie Yuan et al. Scientific Reports
- Phase I trial of olaparib in combination with cisplatin for the treatment of patients with advanced breast, ovarian and other solid tumors
- (2014) J. Balmaña et al. ANNALS OF ONCOLOGY
- A Peptide Mimicking VGLL4 Function Acts as a YAP Antagonist Therapy against Gastric Cancer
- (2014) Shi Jiao et al. CANCER CELL
- VGLL4 functions as a new tumor suppressor in lung cancer by negatively regulating the YAP-TEAD transcriptional complex
- (2014) Wenjing Zhang et al. CELL RESEARCH
- Down-regulation of BTG1 by miR-454-3p enhances cellular radiosensitivity in renal carcinoma cells
- (2014) Xin Wu et al. Radiation Oncology
- Treatment of HER2-positive breast cancer
- (2013) Maria Cristina Figueroa-Magalhães et al. BREAST
- MicroRNA miR-24 enhances tumor invasion and metastasis by targeting PTPN9 and PTPRF to promote EGF signaling
- (2013) W. W. Du et al. JOURNAL OF CELL SCIENCE
- Differential expression of miRNAs in esophageal cancer tissue
- (2013) SHANG-GUO LIU et al. Oncology Letters
- A promiscuous biotin ligase fusion protein identifies proximal and interacting proteins in mammalian cells
- (2012) Kyle J. Roux et al. JOURNAL OF CELL BIOLOGY
- Sleeping Beauty mutagenesis reveals cooperating mutations and pathways in pancreatic adenocarcinoma
- (2012) K. M. Mann et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
- (2011) M. Dowsett et al. JNCI-Journal of the National Cancer Institute
- Triple-Negative Breast Cancer
- (2010) Shaheenah Dawood DRUGS
- Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
- (2010) Andrew Tutt et al. LANCET
- Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1
- (2009) Zhongxing Liang et al. BIOCHEMICAL PHARMACOLOGY
- E2F1 represses β-catenin transcription and is antagonized by both pRB and CDK8
- (2008) Erick J. Morris et al. NATURE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now